After Fox was diagnosed with Parkinson’s disease at age 29, he quickly saw what was missing—and what he could help provide ...
As part of its mission to improve life today for people living with Parkinson's disease while accelerating a cure, The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced the ...
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research marks the eighth year of its Parkinson's IQ + You national event series, traveling across the United ...
- TRPML1 is a promising target 1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement in clinical studies - Bexorg will leverage its ...
Launched in 2019, the free event series has traveled to 18 locations nationwide, empowering people with Parkinson's to better manage the disease, learn about research participation and connect with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results